A Case Series Demonstrating the Spectrum of Invasive Methicillin‐Sensitive Staphylococcus aureus (MSSA) Disease
Case Reports in Infectious Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/crdi/8839477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Infectious Diseases, online erschienen am 25.06.2026. Verfasst von Elisée Mbombo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Kamuzu University of Health Sciences, Southern Region, Blantyre, Malawi. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Staphylococcus aureus , although a common colonizer of skin and mucous membranes in humans, is associated with severe infections in both healthy and debilitated individuals. The mortality induced by invasive MSSA disease is high, especially in patients diagnosed late. In children, skin and joint manifestations are most common. Septic shock is a major contributing factor to early mortality. To date, reported cases of invasive MSSA disease in children are infrequent, especially in Sub‐Saharan Africa. Case Report We present 4 cases of previously healthy children who presented with various clinical manifestations, but skin lesions and fever were common in all of them. They had multisystem involvement and eventually required aggressive multifactorial therapy. Antibiotic treatment was tailored to the results of antimicrobial sensitivity tests following blood culture. Though the hospital stay was quite long, intensive care and appropriate antibiotics contributed to a good prognosis.
Conclusion
In children with invasive MSSA disease, early diagnosis and prompt management are key factors to improved prognosis. Skin lesions with tender joints in a febrile infant should raise suspicion for a staphylococcal infection. Intensive care and infection source control are the cornerstones of the management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology Department, Kamuzu University of Health Sciences, Southern Region, Blantyre, Malawi.
- Laboratory Department, Malawi-Liverpool Wellcome Research Program, Southern Region, Blantyre, Malawi.
- Pediatrics and Child Health Department, Queen Elizabeth Central Hospital, Southern Region, Blantyre, Malawi.
- Trauma and Orthopedics, Surgery Department, Queen Elizabeth Central Hospital, Southern Region, Blantyre, Malawi.
- Emergency Medicine Department, Queen Elizabeth Central Hospital, Southern Region, Blantyre, Malawi.
- School of Public Health, Université Officielle de Mbujimayi, Kasaï Oriental, Mbujimayi, Democratic Republic of the Congo.
ORCID-Profile: Elisée Mbombo, Criss K Mjumbe
Zitieren
APA
Mbombo, E., Ayamie, M., Makina, J., Phiri, D., Banda, N., Maluk, Z., Mahala, M., Chisambiro, H., Nyamulani, N., Phoya, F., Chagaluka, G., Mapemba, P., Mbale, E., Kulapani, D., Kamina, A. N., Mjumbe, C. K., Langton, J., Chimalizeni, Y., & Kawaza, K. (2026). A Case Series Demonstrating the Spectrum of Invasive Methicillin‐Sensitive Staphylococcus aureus (MSSA) Disease. Case Reports in Infectious Diseases, 2026(1). https://doi.org/10.1155/crdi/8839477
Vancouver
Mbombo E, Ayamie M, Makina J, Phiri D, Banda N, Maluk Z, et al. A Case Series Demonstrating the Spectrum of Invasive Methicillin‐Sensitive Staphylococcus aureus (MSSA) Disease. Case Reports in Infectious Diseases. 2026;2026(1). doi:10.1155/crdi/8839477
BibTeX
@article{Mbombo2026,
author = {Mbombo, Elisée and Ayamie, Mubarack and Makina, James and Phiri, Doreen and Banda, Natasha and Maluk, Zainab and Mahala, McPherson and Chisambiro, Humphry and Nyamulani, Nohakhelha and Phoya, Franck and Chagaluka, George and Mapemba, Patrick and Mbale, Emmie and Kulapani, David and Kamina, Alix N and Mjumbe, Criss K and Langton, Josephine and Chimalizeni, Yamikani and Kawaza, Kondwani},
title = {A Case Series Demonstrating the Spectrum of Invasive Methicillin‐Sensitive Staphylococcus aureus (MSSA) Disease},
journal = {Case Reports in Infectious Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crdi/8839477}
}
EUVIMED